{"id":"W3028893532","doi":"10.1200/jco.2020.38.15_suppl.10543","title":"Naxitamab, a new generation anti-GD2 monoclonal antibody (mAb) for treatment of relapsed/refractory high-risk neuroblastoma (HR-NB).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Refractory (planetary science); Internal medicine; Progressive disease; Bone marrow; Surgery; Gastroenterology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002067276,0.0002010897,0.000301597,0.0002172797,0.0001100793,0.0001973707,0.0002628907,0.0001914755,0.001922135],"category_scores_gemma":[0.0001485468,0.00007996117,0.0001503977,0.0001545879,0.00009791267,0.0001130738,0.0001645008,0.0003895907,0.0005297397],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003615952,"about_ca_system_score_gemma":0.0002895722,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005836349,"about_ca_topic_score_gemma":0.002915859,"domain_scores_codex":[0.999936,0.00001811685,0.000005464905,0.000009513663,0.00001787374,0.00001305086],"domain_scores_gemma":[0.9999379,0.000009402233,0.00001794719,0.000004861755,0.00000939656,0.00002047803],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01122081,0.002138014,0.04268982,0.001390665,0.0003409753,0.001887535,0.0002695133,0.00175574,0.2576542,0.0006371011,0.01596051,0.6640552],"study_design_scores_gemma":[0.01920993,0.09261447,0.2536975,0.0006394338,0.0008230817,0.04117005,0.0003106202,0.006111134,0.1562513,0.0007797676,0.4282986,0.00009404367],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.950929,0.03777865,0.001157981,0.0005039998,0.000155949,0.0003785527,0.0009346642,0.0001833281,0.007977797],"genre_scores_gemma":[0.9793784,0.01005359,0.00262425,0.000498163,0.00005313804,0.0002560528,0.002231414,0.0000203475,0.004884606],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001922135,"threshold_uncertainty_score":0.006430149,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1797433798141128,"score_gpt":0.4739177355672513,"score_spread":0.2941743557531384,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}